PRA Health Sciences Stock Price, News & Analysis (NASDAQ:PRAH)

$86.18 +3.19 (+3.84 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$86.18
Today's Range$83.00 - $87.40
52-Week Range$57.72 - $95.90
Volume650,359 shs
Average Volume399,927 shs
Market Capitalization$5.29 billion
P/E Ratio65.29
Dividend YieldN/A
Beta0.32

About PRA Health Sciences (NASDAQ:PRAH)

PRA Health Sciences logoPRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.

Receive PRAH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRAH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PRAH
CUSIPN/A
Phone919-786-8200

Debt

Debt-to-Equity Ratio1.38%
Current Ratio1.01%
Quick Ratio1.01%

Price-To-Earnings

Trailing P/E Ratio65.2883733967682
Forward P/E Ratio21.71
P/E Growth1.12

Sales & Book Value

Annual Sales$2.26 billion
Price / Sales2.43
Cash Flow$3.99 per share
Price / Cash21.61
Book Value$11.88 per share
Price / Book7.25

Profitability

Trailing EPS$1.32
Net Income$68.17 million
Net Margins3.85%
Return on Equity23.33%
Return on Assets7.51%

Miscellaneous

Employees13,000
Outstanding Shares63,790,000

PRA Health Sciences (NASDAQ:PRAH) Frequently Asked Questions

What is PRA Health Sciences' stock symbol?

PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH."

How were PRA Health Sciences' earnings last quarter?

PRA Health Sciences Inc (NASDAQ:PRAH) posted its quarterly earnings data on Wednesday, February, 21st. The medical research company reported $1.04 earnings per share for the quarter, beating analysts' consensus estimates of $1.02 by $0.02. The medical research company earned $568.80 million during the quarter, compared to analysts' expectations of $543.78 million. PRA Health Sciences had a net margin of 3.85% and a return on equity of 23.33%. The firm's revenue for the quarter was up 37.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.71 EPS. View PRA Health Sciences' Earnings History.

When will PRA Health Sciences make its next earnings announcement?

PRA Health Sciences is scheduled to release their next quarterly earnings announcement on Monday, April, 23rd 2018. View Earnings Estimates for PRA Health Sciences.

What guidance has PRA Health Sciences issued on next quarter's earnings?

PRA Health Sciences issued an update on its FY18 earnings guidance on Wednesday, February, 21st. The company provided EPS guidance of $4.00-4.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.06.

Where is PRA Health Sciences' stock going? Where will PRA Health Sciences' stock price be in 2018?

12 brokerages have issued 12 month price objectives for PRA Health Sciences' shares. Their forecasts range from $63.00 to $104.00. On average, they expect PRA Health Sciences' stock price to reach $92.50 in the next year. View Analyst Ratings for PRA Health Sciences.

Who are some of PRA Health Sciences' key competitors?

Who are PRA Health Sciences' key executives?

PRA Health Sciences' management team includes the folowing people:

  • Colin Shannon, Chairman of the Board, President, Chief Executive Officer (Age 57)
  • Linda Baddour, Chief Financial Officer, Executive Vice President (Age 58)
  • David W. Dockhorn Ph.D., Executive Vice President, Corporate Compliance Officer (Age 56)
  • Max C. Lin, Director (Age 36)
  • James C. Momtazee, Director (Age 45)
  • Ali J. Satvat, Director (Age 39)
  • Jeffrey T. Barber, Independent Director (Age 64)
  • Alexander George Dickinson Ph.D., Independent Director

When did PRA Health Sciences IPO?

(PRAH) raised $306 million in an IPO on Thursday, November 13th 2014. The company issued 17,000,000 shares at a price of $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.

Who owns PRA Health Sciences stock?

PRA Health Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.87%), Acadian Asset Management LLC (2.34%), Eagle Asset Management Inc. (1.96%), Wells Fargo & Company MN (1.49%), Bank of New York Mellon Corp (1.44%) and Carillon Tower Advisers Inc. (1.39%). Company insiders that own PRA Health Sciences stock include Colin Shannon, David W Dockhorn, Linda Baddour, Matthew P Young and Pra Investors LP Kkr. View Institutional Ownership Trends for PRA Health Sciences.

Who sold PRA Health Sciences stock? Who is selling PRA Health Sciences stock?

PRA Health Sciences' stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Acadian Asset Management LLC, Wells Fargo & Company MN, Two Sigma Advisers LP, Hood River Capital Management LLC, Deutsche Bank AG, Redmile Group LLC and Renaissance Technologies LLC. Company insiders that have sold PRA Health Sciences company stock in the last year include Colin Shannon, David W Dockhorn, Linda Baddour, Matthew P Young and Pra Investors LP Kkr. View Insider Buying and Selling for PRA Health Sciences.

Who bought PRA Health Sciences stock? Who is buying PRA Health Sciences stock?

PRA Health Sciences' stock was purchased by a variety of institutional investors in the last quarter, including Carillon Tower Advisers Inc., Bank of New York Mellon Corp, Goldman Sachs Group Inc., Eagle Asset Management Inc., Icon Advisers Inc. Co., Penserra Capital Management LLC, Schwab Charles Investment Management Inc. and Allianz Asset Management GmbH. View Insider Buying and Selling for PRA Health Sciences.

How do I buy PRA Health Sciences stock?

Shares of PRA Health Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PRA Health Sciences' stock price today?

One share of PRA Health Sciences stock can currently be purchased for approximately $86.18.

How big of a company is PRA Health Sciences?

PRA Health Sciences has a market capitalization of $5.29 billion and generates $2.26 billion in revenue each year. The medical research company earns $68.17 million in net income (profit) each year or $1.32 on an earnings per share basis. PRA Health Sciences employs 13,000 workers across the globe.

How can I contact PRA Health Sciences?

PRA Health Sciences' mailing address is 4130 PARKLAKE AVENUE SUITE 400, RALEIGH NC, 27612. The medical research company can be reached via phone at 919-786-8200 or via email at [email protected]


MarketBeat Community Rating for PRA Health Sciences (PRAH)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  208 (Vote Outperform)
Underperform Votes:  160 (Vote Underperform)
Total Votes:  368
MarketBeat's community ratings are surveys of what our community members think about PRA Health Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

PRA Health Sciences (NASDAQ:PRAH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.832.902.89
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $92.50$91.00$88.60$84.71
Price Target Upside: 3.94% upside3.42% downside8.00% upside12.71% upside

PRA Health Sciences (NASDAQ:PRAH) Consensus Price Target History

Price Target History for PRA Health Sciences (NASDAQ:PRAH)

PRA Health Sciences (NASDAQ:PRAH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/22/2018Credit Suisse GroupReiterated RatingOutperform -> Outperform$101.00 -> $104.00HighView Rating Details
1/31/2018KeyCorpReiterated RatingBuy$100.00LowView Rating Details
1/24/2018MizuhoDowngradeBuy -> Neutral$86.00HighView Rating Details
12/15/2017Mitsubishi UFJ Financial GroupInitiated CoverageOverweight$102.00LowView Rating Details
12/11/2017BarclaysInitiated CoverageOverweight -> Overweight$94.00MediumView Rating Details
12/1/2017Robert W. BairdSet Price TargetBuy$94.00LowView Rating Details
10/27/2017SunTrust BanksReiterated RatingBuy$101.00N/AView Rating Details
10/26/2017Jefferies GroupReiterated RatingBuy$95.00N/AView Rating Details
8/16/2017Raymond James FinancialInitiated CoverageOutperform -> Outperform$89.00LowView Rating Details
8/10/2017CitigroupReiterated RatingBuy$90.00 -> $93.00LowView Rating Details
6/26/2017Bank of AmericaInitiated CoverageBuy$89.00LowView Rating Details
2/27/2017Avondale PartnersUpgradeUnderperform -> Market Perform$63.00N/AView Rating Details
6/20/2016First AnalysisInitiated CoverageEqual -> Equal Weight$47.00N/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

PRA Health Sciences (NASDAQ:PRAH) Earnings History and Estimates Chart

Earnings by Quarter for PRA Health Sciences (NASDAQ:PRAH)

PRA Health Sciences (NASDAQ PRAH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/23/2018$0.83N/AView Earnings Details
2/21/2018Q4 2017$1.02$1.04$543.78 million$568.80 millionViewN/AView Earnings Details
10/25/2017Q3 2017$0.85$0.88$477.89 million$494.55 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.72$0.62$447.79 million$457.90 millionViewListenView Earnings Details
4/25/2017Q1 2017$0.58$0.60$426.81 million$427.08 millionViewN/AView Earnings Details
2/22/2017Q4 2016$0.64$0.71$405.04 million$413.61 millionViewN/AView Earnings Details
11/2/2016Q316$0.64$0.64$394.87 million$399.80 millionViewN/AView Earnings Details
7/28/2016Q2$0.59$0.63$381.25 million$394.20 millionViewListenView Earnings Details
4/27/2016Q116$0.53$0.55$372.21 million$372.30 millionViewListenView Earnings Details
2/24/2016Q4$0.49$0.59$353.42 million$428.90 millionViewListenView Earnings Details
11/2/2015Q3$0.45$0.52$346.05 million$345.10 millionViewListenView Earnings Details
7/27/2015Q215$0.40$0.47$336.74 million$336.50 millionViewListenView Earnings Details
5/6/2015Q115$0.31$0.41$329.80 million$332.00 millionViewListenView Earnings Details
2/18/2015Q414$0.30$0.35$323.50 million$370.00 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

PRA Health Sciences (NASDAQ:PRAH) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20181$0.92$0.92$0.92
Q3 20181$1.05$1.05$1.05
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for PRA Health Sciences (NASDAQ:PRAH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

PRA Health Sciences (NASDAQ PRAH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 97.15%
Insider Trades by Quarter for PRA Health Sciences (NASDAQ:PRAH)
Insider Trades by Quarter for PRA Health Sciences (NASDAQ:PRAH)

PRA Health Sciences (NASDAQ PRAH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/16/2018Linda BaddourVPSell67,000$90.27$6,048,090.00View SEC Filing  
12/28/2017David W DockhornInsiderSell72,850$90.83$6,616,965.50View SEC Filing  
12/28/2017David W DockhornEVPSell72,850$90.83$6,616,965.5072,850View SEC Filing  
11/16/2017Matthew P YoungDirectorSell5,115$79.90$408,688.50View SEC Filing  
8/14/2017Colin ShannonCEOSell400,000$74.85$29,940,000.00View SEC Filing  
8/14/2017Linda BaddourVPSell100,000$74.85$7,485,000.00View SEC Filing  
8/14/2017Pra Investors L.P. KkrMajor ShareholderSell9,500,000$74.85$711,075,000.00View SEC Filing  
4/17/2017Linda BaddourVPSell196,393$63.59$12,488,630.87124,472View SEC Filing  
3/28/2017Colin ShannonCEOSell50,000$64.00$3,200,000.0050,000View SEC Filing  
3/27/2017David W DockhornInsiderSell85,182$62.00$5,281,284.0055,574View SEC Filing  
2/23/2017Colin ShannonCEOSell100,000$61.50$6,150,000.002,747View SEC Filing  
8/22/2016Colin ShannonCEOSell113,133$51.57$5,834,268.81120,000View SEC Filing  
8/15/2016Linda BaddourVPSell69,380$52.00$3,607,760.0069,380View SEC Filing  
8/12/2016David W. DockhornVPSell107,257$49.00$5,255,593.00View SEC Filing  
5/6/2016Linda BaddourCFOSell92,308$46.70$4,310,783.60View SEC Filing  
5/6/2016Pra Investors L.P. KkrMajor ShareholderSell4,907,692$46.70$229,189,216.40View SEC Filing  
3/8/2016Colin ShannonCEOSell77,019$42.26$3,254,822.94View SEC Filing  
3/8/2016Linda BaddourCFOSell93,000$42.26$3,930,180.00View SEC Filing  
3/8/2016Pra Investors L.P. KkrMajor ShareholderSell4,829,981$42.26$204,114,997.06View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

PRA Health Sciences (NASDAQ PRAH) News Headlines

Source:
DateHeadline
Swiss National Bank Has $7.77 Million Stake in PRA Health Sciences Inc (PRAH)Swiss National Bank Has $7.77 Million Stake in PRA Health Sciences Inc (PRAH)
www.americanbankingnews.com - February 24 at 5:22 AM
PRA Health Sciences (PRAH) PT Raised to $104.00PRA Health Sciences (PRAH) PT Raised to $104.00
www.americanbankingnews.com - February 22 at 6:22 PM
Zacks: Brokerages Anticipate PRA Health Sciences Inc (PRAH) Will Announce Quarterly Sales of $543.65 MillionZacks: Brokerages Anticipate PRA Health Sciences Inc (PRAH) Will Announce Quarterly Sales of $543.65 Million
www.americanbankingnews.com - February 22 at 2:36 AM
PRA Health Sciences (PRAH) Issues Quarterly  Earnings ResultsPRA Health Sciences (PRAH) Issues Quarterly Earnings Results
www.americanbankingnews.com - February 21 at 9:30 PM
PRA Health Sciences (PRAH) Issues FY18 Earnings GuidancePRA Health Sciences (PRAH) Issues FY18 Earnings Guidance
www.americanbankingnews.com - February 21 at 7:04 PM
PRA Health Sciences beats by $0.01, beats on revenuePRA Health Sciences beats by $0.01, beats on revenue
seekingalpha.com - February 21 at 4:55 PM
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Results and Provides Q1 and FY 2018 GuidancePRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Results and Provides Q1 and FY 2018 Guidance
finance.yahoo.com - February 21 at 4:55 PM
PRA Health Sciences reports 4Q lossPRA Health Sciences reports 4Q loss
finance.yahoo.com - February 21 at 4:55 PM
PRA Health Sciences Inc (PRAH) Given Average Rating of "Buy" by AnalystsPRA Health Sciences Inc (PRAH) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - February 21 at 2:30 PM
PRA Health Sciences, Inc. (PRAH)PRA Health Sciences, Inc. (PRAH)
finance.yahoo.com - February 21 at 9:08 AM
$1.03 EPS Expected for PRA Health Sciences Inc (PRAH) This Quarter$1.03 EPS Expected for PRA Health Sciences Inc (PRAH) This Quarter
www.americanbankingnews.com - February 20 at 11:12 PM
PRA Health Sciences (PRAH) Set to Announce Quarterly Earnings on TuesdayPRA Health Sciences (PRAH) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - February 13 at 3:14 AM
PRA Health Sciences Partners with IMPACT2030PRA Health Sciences Partners with IMPACT2030
finance.yahoo.com - February 12 at 4:17 PM
PRA Health Sciences Inc (PRAH) Expected to Post Quarterly Sales of $543.65 MillionPRA Health Sciences Inc (PRAH) Expected to Post Quarterly Sales of $543.65 Million
www.americanbankingnews.com - February 5 at 2:22 AM
PRA Health Sciences Inc (PRAH) Expected to Post Earnings of $1.03 Per SharePRA Health Sciences Inc (PRAH) Expected to Post Earnings of $1.03 Per Share
www.americanbankingnews.com - February 3 at 11:16 PM
BidaskClub Downgrades PRA Health Sciences (PRAH) to BuyBidaskClub Downgrades PRA Health Sciences (PRAH) to Buy
www.americanbankingnews.com - February 3 at 7:06 PM
My Game Solutions, Inc proclaims to transform the sports industry using technology.My Game Solutions, Inc proclaims to transform the sports industry using technology.
www.prnewswire.com - January 29 at 9:34 AM
PRA Health Sciences (PRAH) Stock Rating Lowered by MizuhoPRA Health Sciences (PRAH) Stock Rating Lowered by Mizuho
www.americanbankingnews.com - January 28 at 6:06 PM
PRA Health Sciences Inc (PRAH) Receives Average Rating of "Buy" from AnalystsPRA Health Sciences Inc (PRAH) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - January 27 at 2:12 PM
Interesting PRAH Put And Call Options For March 16thInteresting PRAH Put And Call Options For March 16th
www.nasdaq.com - January 25 at 4:13 PM
PRA Health Sciences to Report Fourth Quarter 2017 EarningsPRA Health Sciences to Report Fourth Quarter 2017 Earnings
finance.yahoo.com - January 25 at 9:23 AM
 Brokerages Expect PRA Health Sciences Inc (PRAH) Will Announce Quarterly Sales of $543.65 Million Brokerages Expect PRA Health Sciences Inc (PRAH) Will Announce Quarterly Sales of $543.65 Million
www.americanbankingnews.com - January 20 at 4:22 PM
Linda Baddour Sells 67,000 Shares of PRA Health Sciences Inc (PRAH) StockLinda Baddour Sells 67,000 Shares of PRA Health Sciences Inc (PRAH) Stock
www.americanbankingnews.com - January 18 at 6:34 PM
Who will Amazon encroach on? A list of big companies in DFW, other HQ2 citiesWho will Amazon encroach on? A list of big companies in DFW, other HQ2 cities
www.bizjournals.com - January 18 at 4:11 PM
Zacks Investment Research Downgrades PRA Health Sciences (PRAH) to HoldZacks Investment Research Downgrades PRA Health Sciences (PRAH) to Hold
www.americanbankingnews.com - January 18 at 12:10 PM
PRA Health Sciences (PRAH) Lifted to Buy at Zacks Investment ResearchPRA Health Sciences (PRAH) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - January 17 at 11:26 AM
PRA Health Sciences Opens New Salt Lake City Clinic - GlobeNewswire (press release)PRA Health Sciences Opens New Salt Lake City Clinic - GlobeNewswire (press release)
globenewswire.com - January 17 at 10:10 AM
PRA Health Sciences Opens New Salt Lake City ClinicPRA Health Sciences Opens New Salt Lake City Clinic
finance.yahoo.com - January 16 at 10:17 AM
PRA Health Sciences (PRAH) Rating Lowered to Buy at BidaskClubPRA Health Sciences (PRAH) Rating Lowered to Buy at BidaskClub
www.americanbankingnews.com - January 5 at 10:20 PM
PRA Health Sciences Inc (PRAH) Expected to Announce Quarterly Sales of $543.72 MillionPRA Health Sciences Inc (PRAH) Expected to Announce Quarterly Sales of $543.72 Million
www.americanbankingnews.com - January 3 at 3:00 PM
PRA Health Sciences Inc (PRAH) EVP Sells $6,616,965.50 in StockPRA Health Sciences Inc (PRAH) EVP Sells $6,616,965.50 in Stock
www.americanbankingnews.com - January 2 at 6:34 PM
David W. Dockhorn Sells 72,850 Shares of PRA Health Sciences Inc (PRAH) StockDavid W. Dockhorn Sells 72,850 Shares of PRA Health Sciences Inc (PRAH) Stock
www.americanbankingnews.com - January 2 at 6:32 PM
From IQVIA to Red Hat: The top insider stock sales of 2017From IQVIA to Red Hat: The top insider stock sales of 2017
finance.yahoo.com - January 2 at 5:31 PM
PRA Health Sciences Inc (PRAH) Given Average Recommendation of "Buy" by BrokeragesPRA Health Sciences Inc (PRAH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - January 2 at 1:42 PM
PRA Health Sciences (PRAH) Given a $87.00 Price Target by Mizuho AnalystsPRA Health Sciences (PRAH) Given a $87.00 Price Target by Mizuho Analysts
www.americanbankingnews.com - December 30 at 5:14 PM
PRA Health (PRAH) Hits 52-Week High on Multiple Positives - NasdaqPRA Health (PRAH) Hits 52-Week High on Multiple Positives - Nasdaq
www.nasdaq.com - December 27 at 2:17 PM
Free Research Reports on These Healthcare Stocks -- Tivity Health, PRA Health Sciences, Quest Diagnostics, and ... - PR Newswire (press release)Free Research Reports on These Healthcare Stocks -- Tivity Health, PRA Health Sciences, Quest Diagnostics, and ... - PR Newswire (press release)
www.prnewswire.com - December 27 at 2:17 PM
PRA Health Sciences (PRAH) Raised to Strong-Buy at BidaskClubPRA Health Sciences (PRAH) Raised to Strong-Buy at BidaskClub
www.americanbankingnews.com - December 27 at 11:48 AM
PRA Health Sciences Leads Other Pharmaceutical Testers With Double The GrowthPRA Health Sciences Leads Other Pharmaceutical Testers With Double The Growth
www.nasdaq.com - December 22 at 10:24 AM
Zacks: Brokerages Anticipate PRA Health Sciences Inc (PRAH) Will Announce Quarterly Sales of $543.72 MillionZacks: Brokerages Anticipate PRA Health Sciences Inc (PRAH) Will Announce Quarterly Sales of $543.72 Million
www.americanbankingnews.com - December 17 at 6:52 AM
PRA Health Sciences (PRAH) Stock Rating Upgraded by BidaskClubPRA Health Sciences (PRAH) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - December 17 at 12:08 AM
PRA Health Sciences (PRAH) Coverage Initiated at Mitsubishi UFJ Financial GroupPRA Health Sciences (PRAH) Coverage Initiated at Mitsubishi UFJ Financial Group
www.americanbankingnews.com - December 15 at 9:58 AM
PRA Health Sciences (PRAH) Research Coverage Started at BarclaysPRA Health Sciences (PRAH) Research Coverage Started at Barclays
www.americanbankingnews.com - December 11 at 9:26 PM
Here's Why You Should Steer Clear of LifePoint (LPNT) StockHere's Why You Should Steer Clear of LifePoint (LPNT) Stock
finance.yahoo.com - December 11 at 10:59 AM
PRA Health Sciences, Inc. (PRAH) Given Consensus Rating of "Buy" by AnalystsPRA Health Sciences, Inc. (PRAH) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - December 8 at 3:52 PM
4 Attractive Stocks to Buy in an Evolving Healthcare Space - Nasdaq4 Attractive Stocks to Buy in an Evolving Healthcare Space - Nasdaq
www.nasdaq.com - December 6 at 4:40 PM
4 Attractive Stocks to Buy in an Evolving Healthcare Space4 Attractive Stocks to Buy in an Evolving Healthcare Space
finance.yahoo.com - December 6 at 4:40 PM
PRA Health Sciences, Inc. – Value Analysis (NASDAQ:PRAH) : December 6, 2017PRA Health Sciences, Inc. – Value Analysis (NASDAQ:PRAH) : December 6, 2017
finance.yahoo.com - December 6 at 4:40 PM
Why Intrexon (XON) Could Be Positioned for a SlumpWhy Intrexon (XON) Could Be Positioned for a Slump
finance.yahoo.com - December 6 at 10:32 AM
Financial Comparison: Celator Pharmaceuticals (CPXX) vs. PRA Health Sciences (PRAH)Financial Comparison: Celator Pharmaceuticals (CPXX) vs. PRA Health Sciences (PRAH)
www.americanbankingnews.com - December 5 at 7:28 PM

SEC Filings

PRA Health Sciences (NASDAQ:PRAH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

PRA Health Sciences (NASDAQ:PRAH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

PRA Health Sciences (NASDAQ PRAH) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.